In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium

FEMS Immunology and Medical Microbiology

Volumn 37, Issue 2-3, 2003, Pages 111-119

  Dunstan, Sarah J ^a,b   Simmons, Cameron P ^a,b   Strugnell, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHO QUAN HOSPITAL   (Viet Nam)

Author keywords

Plasmid stability; Salmonella typhimurium; Vaccine vector

Indexed keywords

ABC TRANSPORTER; BACTERIUM LIPOPOLYSACCHARIDE; DNA FRAGMENT; PLASMID VECTOR; SALMONELLOSIS VACCINE; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RECOMBINANT PLASMID; SALMONELLA TYPHIMURIUM; WESTERN BLOTTING;

EID: 0038094506     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00065-8     Document Type: Article

References (33)

1. Bermudes D., Low B., Pawelek J. Tumor-targeted Salmonella. Highly selective delivery vectors. Adv. Exp. Med. Biol. 465:2000;57-63.
2. Bullas L.R., Ryu J.I. Salmonella typhimurium LT2 strains which are r-m+ for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:1983;471-474.
3. Cardenas L., Clements J.D. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. Vaccine. 11:1993;126-135.
4. Chabalgoity J.A., Khan C.M., Nash A.A., Hormaeche C.E. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol. Microbiol. 19:1996;791-801.
5. Chang A.C., Cohen S.N. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:1978;1141-1156.
6. Chatfield S.N., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., Slater D., Fairweather N.F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology. 10:1992;888-892.
7. Coulson N.M., Fulop M., Titball R.W. Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261. Microb. Pathog. 16:1994;305-311.
8. Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., Chakraborty T., Weiss S. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
9. Darji A., zur Lage S., Garbe A.I., Chakraborty T., Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol. Med. Microbiol. 27:2000;341-349.
10. Fairweather N.F., Chatfield S.N., Makoff A.J., Strugnell R.A., Bester J., Maskell D.J., Dougan G. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1990;1323-1326.
11. Fouts T.R., Tuskan R.G., Chada S., Hone D.M., Lewis G.K. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120. Vaccine. 13:1995;1697-1705.
12. Gentschev I., Sokolovic Z., Kohler S., Krohne G.F., Hof H., Wagner J., Goebel W. Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system. Infect. Immun. 60:1992;5091-5098.
13. Helinski, D.R., Toukdarian, A.E. and Novick, R.P. (1996) Replication control and other stable maintenance mechanisms of plasmids. In: Escherichia coli and Salmonella, (Neidhardt, F.C., Ed.), pp. 2295-2324. ASM Press, Washington, DC.
14. Hohmann E.L., Oletta C.A., Loomis W.P., Miller S.I. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA. 92:1995;2904-2908.
15. Holmes D.S., Quigley M. A rapid boiling method for the preparation of bacterial plasmids. Anal. Biochem. 114:1981;193-197.
16. Hone D., Attridge S., van den Bosch L., Hackett J. A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb. Pathog. 5:1988;407-418.
17. Hormaeche, C.E., Khan, C.M.A., Mastroeni, P., Villarreal, B., Dougan, G., Roberts, M. and Chatfield, S.N. (1995) Salmonella vaccines: Mechanisms of immunity and their use as carriers of recombinant antigens. In: Molecular and Clinical Aspects of Bacterial Vaccine Development (Ala'Aldeen, D.A.A. and Hormaeche, C.E., Eds.), pp. 119-153. Wiley, New York.
18. Karem K.L., Bowen J., Kuklin N., Rouse B.T. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens. J. Gen. Virol. 78:1997;427-434.
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
20. Marsh J.L., Erfle M., Wykes E.J. The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene. 32:1984;481-485.
21. Nakayama K., Kelly S.M., Curtiss R.I. Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology. 6:1988;693-697.
22. Oyston P.C., Williamson E.D., Leary S.E., Eley S.M., Griffin K.F., Titball R.W. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect. Immun. 63:1995;563-568.
23. Roberts, M., Chatfield, S.N. and Dougan, G. (1994) Salmonella as carriers of heterologous antigens. In: Novel Delivery Systems for Oral Vaccines (O'Hagan, D.T., Ed.), pp. 27-58. CRC Press, Boca Raton, FL.
24. Salas V.E., Plebanski M., Castro S., Perales G., Mata E., Lopez S., Arias C.F. Synthesis of the surface glycoprotein of rotavirus SA11 in the aroA strain of Salmonella typhimurium SL3261. Res. Microbiol. 141:1990;883-886.
25. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989). Molecular cloning: A Laboratory manual, 2nd edn. Cold Spring Harbour Laboratory Press, Cold Spring Harbour, NY.
26. Scholz P., Haring V., Wittmann-Liebold B., Ashman K., Bagdasarian M., Scherzinger E. Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. Gene. 75:1989;271-288.
27. Strugnell R.A., Maskell D., Fairweather N., Pickard D., Cockayne A., Penn C., Dougan G. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene. 88:1990;57-63.
28. Sutcliffe, J.G. (1978) Complete Nucleotide Sequence of the Escherichia Coli Plasmid pBR322. Cold Spring Harbour Symp. Quant. Biol. 43, 77-90.
29. Tarkka E., Muotiala A., Karvonen M., Saukkonen L.K., Sarvas M. Antibody production to a meningococcal outer membrane protein cloned into live Salmonella typhimurium aroA vaccine strain. Microb. Pathog. 6:1989;327-335.
30. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
31. Turner S.J., Carbone F.R., Strugnell R.A. Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect. Immun. 61:1993;5374-5380.
32. Xiang R., Lode H.N., Chao T.H., Ruehlmann J.M., Dolman C.S., Rodriguez F., Whitton J.L., Overwijk W.W., Restifo N.P., Reisfeld R.A. An autologous oral DNA vaccine protects against murine melanoma. Proc. Natl. Acad. Sci. USA. 97:2000;5492-5497.
33. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 33:1985;103-119.